Work

Supplementary Figure 8 from Concomitant Targeting of Tumor Cells and Induction of T-cell Response Synergizes to Effectively Inhibit Trastuzumab-Resistant Breast Cancer

Year: 2023

Type: supplementary-materials

Abstract: PDF file - 206K, No significant changes in the number of tumor infiltrating T cells (including CD8+ and CD4+ ) upon the addition of anti-CTLA-4 mAb to HER2/Neu antibody and triciribine combination treatment

DOI: 10.1158/0008-5472.22395648.v1

Authors: Qingfei Wang, Shau-Hsuan Li, Hai Wang, Yi Xiao, Ozgur Sahin, Samuel W. Brady, Ping Li, Hailiang Ge, Elizabeth M. Jaffee, William J. Muller, Gabriel N. Hortobagyi, Dihua Yu

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361805293

Cites:

Cited by:

Related to: 10